Drug intelligence / Profile preview

rubidium chloride

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

Rubidium chloride is an inorganic salt primarily utilized as a research tool to study cation transport in vivo. It allows for the measurement of changes in plasma and intra-erythrocytic rubidium concentrations following oral administration. This method is particularly useful for assessing alterations in Na+, K+-ATPase activity, as demonstrated in studies involving digoxin administration and chronic renal failure patients. Its disposition provides insights into widespread changes in this crucial enzyme's function.

Targets

ATP1A (Sodium/potassium-transporting ATPase)

Beyond the preview

Go deeper on rubidium chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on rubidium chloride.

Explore the full profile